Texas Gov. Greg Abbott (R) signed a first-in-the nation bill Wednesday that positions the state as a leader in researching a natural psychedelic drug’s use in the treatment of opioid use disorder and other mental health conditions.
Ibogaine, derived from a West Central African shrub, has shown in some studies to alleviate the symptoms of opioid dependence, traumatic brain injuries, post-traumatic stress disorder, anxiety and depression. Its regulation as a Schedule I controlled substance in the United States has limited research into its use in humans.
Already a subscriber? Sign in